|Bid||9.85 x 1100|
|Ask||9.87 x 3000|
|Day's Range||9.85 - 9.91|
|52 Week Range||9.83 - 10.89|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Ginkgo Bioworks, Inc. ("Ginkgo"), which recently announced a business combination with Soaring Eagle Acquisition Corp. (Nasdaq: SRNG), is scheduled to participate in the following upcoming conferences:
Ginkgo Bioworks, Inc. ("Ginkgo"), which is building the leading horizontal platform for cell programming, today announced that it will hold a virtual Investor Day on Thursday, June 24, 2021, beginning at 1:00pm ET. The Investor Day will feature conversations with Ginkgo's Founders, a virtual Foundry Tour, presentations by Ginkgo senior management, and a showcase of customer programs. The Investor Day event registration and webcast details are available at https://www.ginkgobioworks.com/investors/.
Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018-2020 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating Soaring Eagle Acquisition Corp. ("SRNG" or the "Company") (SRNG) relating to its proposed merger with Ginkgo Bioworks, Inc. Under the terms of the agreement, SRNG will acquire Ginkgo through a reverse merger, with Ginkgo emerging as a publicly traded company.